EUCTR2008-007047-13-IT进行中（未招募）不适用
Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis. - ND
OSPEDALE POLICLINICO S. MATTEO0 个研究点开始时间: 2009年3月30日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients of 18-70 years old; Patients in emodialysis suitable for kidney transplantation; patients with PRA > 50%; absence of active infections and procalcitonine in the normality ranges; absence of neoplastic processes; absence of active heart diseases; signed informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Absence of one of the inclusion criteria.
研究者
相似试验
已完成
不适用
Kidney transplantation without immunosuppression using Stem cells Versus donor specific transfusioCTRI/2018/05/014333Self20
招募中
不适用
Observational study of kidney transplant patietns (Japan Academic Consortium of Kidney Transplantation : JACK)kidney transplantationJPRN-UMIN000018327Tokyo Women's Medical University2,000
招募中
1 期
Therapy for prevention of renal failure using mesenchymal stem cells cultured in serum-free mediumDiabetic kidney disease, IgA nephropathy, NephrosclerosisChronic kidney diseaseJPRN-jRCTb060220083akashima Ayumu10
尚未招募
不适用
Prevention of rejection after transplantation by donor-specific suppression immunity with donor exosomes (protocol id: DOBEX)liver grafts10019654rejectionNL-OMON41041Erasmus MC, Universitair Medisch Centrum Rotterdam40
已完成
Unknown
Treatment of renal transplant recipients with low bone mineral density and vascular calcification: a prospective study of alendronate therapy.Kidney transplant recipients for secondary osteoporosis and vascular calcificationJPRN-jRCT1091220155Masanori Okamoto20